A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors
NCT07409766
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Advanced Malignant Tumors
Interventions
BIOLOGICAL:
CAR-M
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences